Pioneering and Delivering the Future of Genomic Medicines Forward-Looking Statements 2 Four Clinical-Stage Programs Advancing Towards Potential Commercialization In-House Manufacturing Provides Flexibility and Control Sangamo in 2023: Value Thesis 1 2 Pioneer in CAR-Tregs • TX200 renal transplant Ph1/2 study progresses, with possible acceleration to prove biology and platform value. Second wave of potentially transformative autoimmune and neurology programs advancing into the clinic • Second of four wholly- ...